David de Weese

GWG Life LLC engages in the provision of life insurance services. Through LifeCareXchange, it offers protection, income, LTC benefit, and lump sump benefits. The company was founded in 2006 and is headquartered in Minneapolis, MN.

Founded in 1991 by Philip Paul, Paul Capital Partners LP is a private equity firm located in San Francisco with additional offices in New York City, Hong Kong, London, Paris and São Paulo.

Cygnus Therapeutic Systems develops and manufactures non-invasive glucose monitoring devices. The private company is based in Redwood City, CA.

M6 Pharmaceuticals, Inc. manufactures and sells pharmaceutical products. The private company is based in New York. The American company was founded by David H. de Weese.

GWG Holdings, Inc. engages in the business of life insurance secondary market. It offers liquidity solutions and services for the owners of illiquid investments. It operates through the following segments: Secondary Life Insurance, Beneficient, and Corporate and Other. The Secondary Life Insurance segment seeks to earn non-correlated yield from the portfolio of life insurance policies. The Beneficient segment includes assets and operations of Ben LP and its subsidiaries. The company was founded by Jon R. Sabes, Paul A. Siegert, and Steven F. Sabes in February 2006 and is headquartered in Dallas, TX.

Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France.